|
Management
|
|
Dr. Li Zhong Yuan, Chairman of
the Board, has over 19 years of experience in entrepreneurship;
principal investment; finance; and academia. Dr. Li held senior positions in cross border structured
products / asset swap / repackaging with major international investment
banks, including Bankers Trust, Salomon Brothers, and IBJ Asia and was
a Director of Rabobank International before pursuing his own principal
investment and entrepreneurial operation in early 2000. Dr. Li received
his Ph.D. in Mathematics with best dissertation for the year honor from
the University
of Michigan and
subsequently worked as a C.L.E. Moore Instructor in Mathematics at the
MIT. Dr. Li is a member of the International Advisory Board of the UCSD
Graduate School of International Relations and Pacific Studies, and also
served on boards of a number of public and private companies.
back to top
|
|
|
|
Mr. Lee Jong-Dae, Executive Director, is an experienced international lawyer and
investment banker in charge of public and investor relations and legal
affairs for the Group. He began his practice in Washington,
D.C. where he specialized in
international trade matters, and moved to Hong
Kong in 1988 to join Coudert Brothers. As a partner of
Coudert Brothers, he practiced in the corporate and finance areas
focusing on regional cross border transactions, often involving China.
He left full time law practice in 1997 to become a senior investment
banker for Rabobank International, Citigroup, and certain other
financial institutions, with broad responsibilities for complex
cross-border transactions. He serves on the Executive Committee of Lee
International IP & Law Group, Executive Committee of the Young
President’s Organization, Beijing Chapter, and is an advisor to and
director of several corporations. He received his undergraduate degree
in economics from Haverford College, Pennsylvania, and later obtained his Doctor of
Jurisprudence from Georgetown
University, Washington,
D.C.
back to top
|
|
|
|
Mr. Zhou Bao Yi, Executive Director,
is charge of the Group’s finance; accounting and administration for the
Group. Mr. Zhou has many years of administrative experience in
organizational management and was the Chief Financial Officer;
President and Chairman in Northeastern Electric Transmission and
Transformation Equipment Group Ltd. – a large state-owned enterprise
with more than 67,000 staffs and workers. Mr. Zhou received his Master
degree in economics from People’s University, PRC; Doctoral
degree in Management from Liaoning
University and is
a certified Senior Accountant in the PRC.
back to top
|
|
|
Ms. Zhang,
Jane, Vice President, is in charge of the operation of the Group’s
subsidiary Shanghai Harvest Network Technology Co., Ltd. as its General Manager,
and has extensive operating and managerial experiences of 25 years with
Chinese financial services industry and wide range of contacts in Chinese
government and business community. Previously Ms. Zhang was Assistant
President of CITIC Bank, Shanghai.
Ms. Hu has a BA from University
of Foreign Trade
and Economy and MBA from Macau University of Science and Technology.
back to top
Dr. Lu, Pei, Vice
President of Customer Services and Chief Medical Director, is in
charge of customer service and maintenance and hospital access for Group’s healthcare service business. Dr. Lu, after graduating with a medical degree
from Shanghai Medical University, worked as a well regarded surgeon at leading
hospitals both in Shanghai and Belgium for 12 years. Dr. Lu holds a master in
International Healthcare Management from Tanaka Business School, Imperial College of London, UK, and a master in
bio-medicine from University of Luven, Belgium. Dr. Lu also worked as a site doctor for International SOS in 1994.
|
back to top
|
|
|
|
Mr. Ren, Jun, Vice President
of Diagnostic Products, is in charge of the Group’s distribution
business in diagnostic devices; equipments and reagents. Mr. Ren possesses
more than 14 years of experience in distributing reagents, diagnostic
devices and equipments into hospitals throughout China, and was
previously a star salesman at Beckman Coulter for the Greater China
region for several years before moving into his own entrepreneurial
pursue for 5 years. Mr. Ren has a BS in biomedicine from Shanghai
University of Science and Technology.
back
to top
|
|
|
|
|
Mr. Yoo, Fred, Vice President of International Operations, is in charge of international
operations for Group’s healthcare service business, and has more than
15 years of senior management experiences with global operation
strategy, operations management and customer services at leading world
organizations across insurance, financial services, and
telecommunications. Prior to CHC, Mr. Yoo assumed senior management
positions at AIG/AIU, SWIFT and Telcordia responsible for global
operations and customer services. Mr. Yoo worked at worldwide/regional
headquarters in US, Europe and Asia. Mr. Yoo received MBA from Columbia
University, M.S in Computer Science from Brown University and B.S. in
Mathematics from Harvey Mudd College. He is a certified project
manager.
|
|
back
to top
|
|
Ms. Yu, Amy, Chief Operating Officer and Vice President of
the Group, is in charge of the Group’s daily operating activities and
has the overall responsibility for the Group’s healthcare service
business as General Manager of the Group’s subsidiary Beijing Universal
Medical Assistance Co., Ltd.. Ms. Yu is a successful entrepreneur who
built up her own financial; accounting; operational and managerial
consulting business from scratch, now with offices both in Shanghai and
Beijing and client coverage throughout China including Inner Mongolia
Mengniu Dairy Industry (Group) Co., Ltd. etc. Ms. Yu has extensive
experience in service sales and marketing in China and proven track
record in business management and is an official financial consultant
for China Association for Small and Medium Enterprises. Ms. Yu has a BS
in accounting from Shanghai University of Finance and Economy and is a
CPA.
|
|
back to top
|
|
|
|
Advisors
|
Mr. Robert Ellsworth, advisor, is
Chairman & Founding Director of Hamilton BioVentures and has had
a distinguished career as both a public servant and businessman. His
service in the United States government includes being Deputy and Assistant
Deputy Secretary of Defense, U.S. Ambassador to NATO, assistant to
the President, a Member of Congress, and (unpaid) Consultant to the
Office of the Secretary of Defense. Among Mr. Ellsworth's business
accomplishments are, being a General Partner at Lazard Freres &
Co. He has also served as Chairman of Fairchild Space and Defense
Corp. and Howmet Corp. and as a board member for The Hamilton Group,
Price Communications Corporation, Voice Compression Technologies,
Inc., Warner Communications, Inc., General Dynamics Corporation,
Allied Chemical, The Aerospace Corporation, and DBA Systems, Inc. Mr.
Ellsworth received a BSME at the University of Kansas and a JD at the
University of Michigan; he is also a veteran of the United States
Navy.
back to top
|
|
|
Dr. Paul
Vanhoutte, advisor, has had more
than 35 years of academic and medical research and development
experience specializing in physiology, drug discovery and the
preclinical development of drugs. Dr.Vanhoutte received his B.S., M.S.,
and M.D. at the University
of Ghent
and the equivalent of a Ph.D. at the University of Antwerp.
Dr. Vanhoutte was a Professor and the Head of the Department of
Pharmacology at the University of Antwerp, Professor of Physiology and
Pharmacology at the Mayo Clinic in Rochester, MN, USA, Professor of
Medicine, Pharmacology and Physiology and Director at the Center for
Experimental Therapeutics at the Baylor College of Medicine in Houston,
TX, USA and the VP of research and development and Director of
Discovery Research at the Institute de Recherches Internationales
Servier in Courbevoie (Paris, France). He is currently a Distinguished
Visiting Professor and the Director of the BioPharmaceutical Development Center
at the University of Hong
Kong.
He is also an Honorary Professor or Visiting Professor at numerous
leading academic institutions in China
such as Peking Union Medical College,
the Institute of Materia Medica of Beijing, Beijing Medical University,
and Nanjing
Medical University.
Dr. Pamela J.
Newman, advisor, is an international insurance broker specializing in
Fortune 500 clients worldwide and Executive
Vice President of AON Corporation. She currently is on the Board of
the McGowan Transplant Center, the Brain Trauma Foundation; American
ORT and the Medical Center Advisory Board of the New York
Hospital-Cornell Medical Center etc.., In
addition to serving on many corporate boards, She is also a
Trustee of The American University of Paris, and a member of the Council on Foreign Relations;
Economic Club of NY; the Business Committee of the Metropolitan Museum
of Art; the Corporate Board of Carnegie Hall; and the University of
Michigan Horace Rackham Graduate School Board of Advisors. She earned a B.A., M.A. and Ph.D. from The
University of Michigan.
Dr. Philippa
Malmgren, advisor, has extensive experience
as a senior investment banker and in advising governmental officials,
boards of central banks, and fund managers about the political and
policy developments that affect financial markets. She holds a B.A.
from Mount Vernon College
and a M.Sc. and a Ph.D. from the London School of Economics. Dr.
Malmgren was an advisor and special assistant to the President of the United
States on financial
market issues in the White House, she was the Deputy Head of Global
Investment Strategy at UBS Warburg in London,
and the Chief Currency Strategist at Bankers Trust in Asia based in Hong Kong.
Currently, Dr. Malmgren is the President of the Canonbury Group, a
financial services company based in London
that specializes in independent research/advisory services and asset
management services. She is also the Chairman of the Working Group on
Terrorism Risks and the World Economy for the Royal Institute for
International Affairs in London.
|
|
